DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Brown Jr RS, Buti M, Rodrigues L. et al.
Glecaprevir/pibrentasvir for 8weeks in treatment-naive patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial.
J Hepatol 2020;
72: 441-449
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.